Company Profile

Advanced Chemotherapy Technologies Inc (AKA: ACT)
Profile last edited on: 8/31/2021      CAGE: 7TN07      UEI: CYKRUDNRVZ85

Business Identifier: Device to infuse chemotherapies into poorly vascularized tumors
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2301 Stonehenge Drive Suite 115
Raleigh, NC 27615
   (919) 368-0522
Location: Single
Congr. District: 02
County: Wake

Public Profile

Structured around developing breakthrough combination drug-device technologies to tackle cancers that are difficult to treat, Advanced Chemotherapy Technologies Inc (aka ACT) is a medical company having currently a particular focus on pancreatic cancer. The firm's lead product is the first-in-class to combine iontophoresis drug delivery with an implantable delivery system to target drug delivery with laser-like precision. Advanced Chemotherapy Technologies drug delivery technology was first developed at and licensed from the University of North Carolina at Chapel Hill in conjunction with UNC Lineberger Comprehensive Cancer Center.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Anthony (Tony) Voiers -- Founder and CEO

  William Daunch -- CTO

  Francisco J De Ana Arbeloa

  Joseph M Desimone -- Executive Chairman and Co-Founder

  Jen Jen Yeh -- Founder

Company News

There are no news available.